<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S1569199316300042</prism:url><dc:identifier>doi:10.1016/j.jcf.2016.02.013</dc:identifier><eid>1-s2.0-S1569199316300042</eid><prism:doi>10.1016/j.jcf.2016.02.013</prism:doi><pii>S1569-1993(16)30004-2</pii><dc:title>Highlighting the impact of cascade carrier testing in cystic fibrosis families </dc:title><prism:publicationName>Journal of Cystic Fibrosis</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>
               Original Article
            </pubType><prism:issn>15691993</prism:issn><prism:volume>15</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:startingPage>452</prism:startingPage><prism:endingPage>459</prism:endingPage><prism:pageRange>452-459</prism:pageRange><prism:number>4</prism:number><dc:format>text/xml</dc:format><prism:coverDate>2016-07-31</prism:coverDate><prism:coverDisplayDate>July 2016</prism:coverDisplayDate><prism:copyright>© 2016 European Cystic Fibrosis Society. Published by Elsevier B.V.</prism:copyright><prism:publisher>European Cystic Fibrosis Society. Published by Elsevier B.V.</prism:publisher><dc:creator>Duguépéroux, Ingrid</dc:creator><dc:creator>L'Hostis, Carine</dc:creator><dc:creator>Audrézet, Marie-Pierre</dc:creator><dc:creator>Rault, Gilles</dc:creator><dc:creator>Frachon, Irène</dc:creator><dc:creator>Bernard, Rémy</dc:creator><dc:creator>Parent, Philippe</dc:creator><dc:creator>Blayau, Martine</dc:creator><dc:creator>Schmitt, Sébastien</dc:creator><dc:creator>Génin, Emmanuelle</dc:creator><dc:creator>Férec, Claude</dc:creator><dc:creator>Scotet, Virginie</dc:creator><dc:description>
               Abstract
               
                  Background
                  Cascade carrier testing within cystic fibrosis (CF) affected families offers relatives of CF patients the opportunity to know their status regarding the mutation that segregates within their family, and thus to make informed reproductive choices. As an Australian study has recently shown that this test seemed underused, we searched to assess uptake of this test in a European area where CF is common, and to report its public health implications.
               
               
                  Methods
                  This study relied on 40 CF-affected families from western Brittany, France. Investigations included drawing of family trees and registration of carrier tests performed in those families.
               
               
                  Results
                  Of the 459 relatives eligible for testing, 185 were tested, leading to an adjusted uptake rate of testing of 40.7% (95% CI: [34.1%; 47.3%]). The main predictors for having testing were being female (p=0.031) and having a high prior risk (p&lt;0.001). Planning a pregnancy or expecting a child (reported in at least 38.4% of tested relatives) also appeared critical in choosing to be tested. Overall, carrier testing allowed to reassure more than 1/4 of the relatives and to detect five new 1-in-4 at-risk couples who then requested prenatal diagnosis.
               
               
                  Conclusions
                  This observational study assesses, for first time in Europe, uptake of CF cascade carrier testing within CF families, which is a critical tool to reassure non-carriers and to detect early new at-risk couples.
               
            </dc:description><openaccess>1</openaccess><openaccessArticle>true</openaccessArticle><openaccessType>Full</openaccessType><openArchiveArticle>true</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType>ElsevierBranded</openaccessSponsorType><openaccessUserLicense>http://www.elsevier.com/open-access/userlicense/1.0/</openaccessUserLicense><dcterms:subject>Cystic fibrosis</dcterms:subject><dcterms:subject>
                     CFTR
                  </dcterms:subject><dcterms:subject>Cascade carrier testing</dcterms:subject><dcterms:subject>Genetic counseling</dcterms:subject><dcterms:subject>Predictors</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S1569199316300042" rel="self"/><link href="https://www.sciencedirect.com/science/article/pii/S1569199316300042" rel="scidir"/></coredata><objects><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="211" height="164" size="5760">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="122" height="163" size="5061">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="190" height="164" size="6022">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-gr3.sml?httpAccept=%2A%2F%2A</object><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="627" height="486" size="39633">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="359" height="479" size="29732">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="707" height="609" size="61752">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2776" height="2152" size="326787">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="1592" height="2126" size="248827">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="3129" height="2695" size="709473">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="mmc1" category="standard" type="APPLICATION" multimediatype="Microsoft Word file" mimetype="application/word" size="54784">https://api.elsevier.com/content/object/eid/1-s2.0-S1569199316300042-mmc1.doc?httpAccept=%2A%2F%2A</object></objects><scopus-id>84962177703</scopus-id><scopus-eid>2-s2.0-84962177703</scopus-eid><pubmed-id>27013383</pubmed-id><link href="https://api.elsevier.com/content/abstract/scopus_id/84962177703" rel="abstract"/><originalText><xocs:doc xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd" xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd">
   <xocs:meta>
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>272296</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291911</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>Journal of Cystic Fibrosis</xocs:srctitle>
      <xocs:normalized-srctitle>JOURNALCYSTICFIBROSIS</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20160322">2016-03-22</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20160322">2016-03-22</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20160728">2016-07-28</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20160728">2016-07-28</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2016-07-25T13:46:34</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S1569199316300042</xocs:eid>
      <xocs:pii-formatted>S1569-1993(16)30004-2</xocs:pii-formatted>
      <xocs:pii-unformatted>S1569199316300042</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.jcf.2016.02.013</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.1</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S1569199316X00057</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20180701">2018-07-01T00:30:49.49494Z</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20160701</xocs:date-search-begin>
      <xocs:date-search-end>20160731</xocs:date-search-end>
      <xocs:year-nav>2016</xocs:year-nav>
      <xocs:indexeddate epoch="1458623588">2016-03-22T05:13:08.507206Z</xocs:indexeddate>
      <xocs:articleinfo>articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issfirst issn issnnorm issuelist itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdateend pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table e-component body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast grantnumber grantsponsor otherkwds primabst pubtype ref</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>1569-1993</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>15691993</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>15</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>15</xocs:volume>
      </xocs:volume-list>
      <xocs:iss-first>4</xocs:iss-first>
      <xocs:issue-list>
         <xocs:issue>4</xocs:issue>
      </xocs:issue-list>
      <xocs:vol-iss-suppl-text>Volume 15, Issue 4</xocs:vol-iss-suppl-text>
      <xocs:sort-order>12</xocs:sort-order>
      <xocs:first-fp>452</xocs:first-fp>
      <xocs:last-lp>459</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>452</xocs:first-page>
         <xocs:last-page>459</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>201607</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>July 2016</xocs:cover-date-text>
      <xocs:cover-date-start>2016-07-01</xocs:cover-date-start>
      <xocs:cover-date-end>2016-07-31</xocs:cover-date-end>
      <xocs:cover-date-year>2016</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Diagnosis/Screening</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>© 2016 European Cystic Fibrosis Society. Published by Elsevier B.V.</xocs:copyright-line>
      <xocs:normalized-article-title>HIGHLIGHTINGIMPACTCASCADECARRIERTESTINGINCYSTICFIBROSISFAMILIES</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>DUGUEPEROUX</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>I</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Population and methods</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Study design and setting</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Study population</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Data collection and management</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Statistical analysis</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Results</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Description of enrolled patients</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Description of enrolled families</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Assessment of uptake of cascade carrier testing</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Predictors of uptake of cascade carrier testing</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>Time taken to perform the test and age at testing</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>3.5.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Time taken to perform the test (<ce:cross-ref id="cf0250" refid="f0010">Fig. 2</ce:cross-ref>a)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>3.5.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Age of eligible relatives at time of testing (<ce:cross-ref id="cf0255" refid="f0010">Fig. 2</ce:cross-ref>b)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>3.6</xocs:item-toc-label>
               <xocs:item-toc-section-title>Public health implications of cascade carrier testing</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>4</xocs:item-toc-label>
            <xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Conflicts of interest</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:appendices">
            <xocs:item-toc-label>Appendix A</xocs:item-toc-label>
            <xocs:item-toc-section-title>Supplementary data</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="rf0005">
            <xocs:ref-normalized-surname>WELSH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1993</xocs:ref-pub-year>
            <xocs:ref-first-fp>1251</xocs:ref-first-fp>
            <xocs:ref-last-lp>1254</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0010">
            <xocs:ref-normalized-surname>KEREM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1989</xocs:ref-pub-year>
            <xocs:ref-first-fp>1073</xocs:ref-first-fp>
            <xocs:ref-last-lp>1080</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0015">
            <xocs:ref-normalized-surname>RIORDAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1989</xocs:ref-pub-year>
            <xocs:ref-first-fp>1066</xocs:ref-first-fp>
            <xocs:ref-last-lp>1073</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0020">
            <xocs:ref-normalized-surname>ROMMENS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1989</xocs:ref-pub-year>
            <xocs:ref-first-fp>1059</xocs:ref-first-fp>
            <xocs:ref-last-lp>1065</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0025">
            <xocs:ref-normalized-surname>MARKS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-first-fp>156</xocs:ref-first-fp>
            <xocs:ref-last-lp>159</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0030">
            <xocs:ref-normalized-surname>BAIG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>68</xocs:ref-first-fp>
            <xocs:ref-last-lp>70</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0035">
            <xocs:ref-normalized-surname>CODY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>140</xocs:ref-first-fp>
            <xocs:ref-last-lp>142</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0040">
            <xocs:ref-normalized-surname>HELDERMANVANDENENDEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>236</xocs:ref-first-fp>
            <xocs:ref-last-lp>242</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0045">
            <xocs:ref-normalized-surname>CASTELLANI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>145</xocs:ref-first-fp>
            <xocs:ref-last-lp>151</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0050">
            <xocs:ref-normalized-surname>MASSIE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>978</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0055">
            <xocs:ref-normalized-surname>ZVEREFF</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>539</xocs:ref-first-fp>
            <xocs:ref-last-lp>546</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0060">
            <xocs:ref-normalized-surname>TURNER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1993</xocs:ref-pub-year>
            <xocs:ref-first-fp>163</xocs:ref-first-fp>
            <xocs:ref-last-lp>165</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0065">
            <xocs:ref-normalized-surname>SUPER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1994</xocs:ref-pub-year>
            <xocs:ref-first-fp>1462</xocs:ref-first-fp>
            <xocs:ref-last-lp>1467</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0070">
            <xocs:ref-normalized-surname>SURH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1994</xocs:ref-pub-year>
            <xocs:ref-first-fp>632</xocs:ref-first-fp>
            <xocs:ref-last-lp>637</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0075">
            <xocs:ref-normalized-surname>SORENSON</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>121</xocs:ref-first-fp>
            <xocs:ref-last-lp>129</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0080">
            <xocs:ref-normalized-surname>BORGO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>82</xocs:ref-first-fp>
            <xocs:ref-last-lp>90</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0085">
            <xocs:ref-normalized-surname>LAFAYETTE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>17</xocs:ref-first-fp>
            <xocs:ref-last-lp>36</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0090">
            <xocs:ref-normalized-surname>MCCLAREN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>1084</xocs:ref-first-fp>
            <xocs:ref-last-lp>1089</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0095">
            <xocs:ref-normalized-surname>SCOTET</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>247</xocs:ref-first-fp>
            <xocs:ref-last-lp>254</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0100">
            <xocs:ref-normalized-surname>AUDREZET</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>108</xocs:ref-first-fp>
            <xocs:ref-last-lp>116</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0105">
            <xocs:ref-normalized-surname>FEREC</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1992</xocs:ref-pub-year>
            <xocs:ref-first-fp>188</xocs:ref-first-fp>
            <xocs:ref-last-lp>191</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0110">
            <xocs:ref-normalized-surname>SCOTET</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2000</xocs:ref-pub-year>
            <xocs:ref-first-fp>789</xocs:ref-first-fp>
            <xocs:ref-last-lp>794</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0115">
            <xocs:ref-normalized-surname>HANLEY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-first-fp>364</xocs:ref-first-fp>
            <xocs:ref-last-lp>375</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0120">
            <xocs:ref-normalized-surname>SCOTET</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>197</xocs:ref-first-fp>
            <xocs:ref-last-lp>202</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0125">
            <xocs:ref-normalized-surname>DUGUEPEROUX</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>338</xocs:ref-first-fp>
            <xocs:ref-last-lp>344</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>I</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0130">
            <xocs:ref-normalized-surname>FORREST</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>122</xocs:ref-first-fp>
            <xocs:ref-last-lp>128</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0135">
            <xocs:ref-normalized-surname>DAGINCOURTCANNING</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-first-fp>114</xocs:ref-first-fp>
            <xocs:ref-last-lp>123</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0140">
            <xocs:ref-normalized-surname>HAREL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-first-fp>489</xocs:ref-first-fp>
            <xocs:ref-last-lp>494</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0145">
            <xocs:ref-normalized-surname>SWEENY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>263</xocs:ref-first-fp>
            <xocs:ref-last-lp>288</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0150">
            <xocs:ref-normalized-surname>BRAEKELEER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2001</xocs:ref-pub-year>
            <xocs:ref-first-fp>263</xocs:ref-first-fp>
            <xocs:ref-last-lp>268</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0155">
            <xocs:ref-normalized-surname>DENAYER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1992</xocs:ref-pub-year>
            <xocs:ref-first-fp>104</xocs:ref-first-fp>
            <xocs:ref-last-lp>111</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0160">
            <xocs:ref-normalized-surname>MILLER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1992</xocs:ref-pub-year>
            <xocs:ref-first-fp>236</xocs:ref-first-fp>
            <xocs:ref-last-lp>242</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0165">
            <xocs:ref-normalized-surname>MCCLAREN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>533</xocs:ref-first-fp>
            <xocs:ref-last-lp>540</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="rf0170">
            <xocs:ref-normalized-surname>HENNEMAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>324</xocs:ref-first-fp>
            <xocs:ref-last-lp>331</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>DUGUEPEROUXX2016X452</xocs:refkey3>
         <xocs:refkey4lp>DUGUEPEROUXX2016X452X459</xocs:refkey4lp>
         <xocs:refkey4ai>DUGUEPEROUXX2016X452XI</xocs:refkey4ai>
         <xocs:refkey5>DUGUEPEROUXX2016X452X459XI</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="1" is-open-archive="1">Full</xocs:oa-article-status>
         <xocs:oa-access-effective-date>2018-07-01T00:20:50Z</xocs:oa-access-effective-date>
         <xocs:oa-access-inherited-from winid="http://vtw.elsevier.com/content/oaw/15691993_P2Y_ESBranded" wintype="OpenArchive">OA-Window</xocs:oa-access-inherited-from>
         <xocs:oa-sponsor>
            <xocs:oa-sponsor-type>ElsevierBranded</xocs:oa-sponsor-type>
         </xocs:oa-sponsor>
         <xocs:oa-user-license>http://www.elsevier.com/open-access/userlicense/1.0/</xocs:oa-user-license>
      </xocs:open-access>
      <xocs:self-archiving>
         <xocs:sa-start-date>2017-07-28T00:00:00Z</xocs:sa-start-date>
         <xocs:sa-embargo-status>UnderEmbargo</xocs:sa-embargo-status>
         <xocs:sa-user-license>http://creativecommons.org/licenses/by-nc-nd/4.0/</xocs:sa-user-license>
      </xocs:self-archiving>
      <xocs:copyright-info>
         <xocs:cp-notices>
            <xocs:cp-notice lang="en">© 2016 European Cystic Fibrosis Society. Published by Elsevier B.V.</xocs:cp-notice>
         </xocs:cp-notices>
         <xocs:cp-license-lines>
            <xocs:cp-license-line lang="en">This article is made available under the Elsevier license.</xocs:cp-license-line>
         </xocs:cp-license-lines>
      </xocs:copyright-info>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S1569-1993(16)30004-2</xocs:pii-formatted>
         <xocs:pii-unformatted>S1569199316300042</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S1569199316300042</xocs:eid>
         <xocs:doi>10.1016/j.jcf.2016.02.013</xocs:doi>
         <xocs:cid>272296</xocs:cid>
         <xocs:timestamp>2016-07-28T08:29:30.350452-04:00</xocs:timestamp>
         <xocs:cover-date-start>2016-07-01</xocs:cover-date-start>
         <xocs:cover-date-end>2016-07-31</xocs:cover-date-end>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/MAIN/application/pdf/836e2301e26a98d345e8082d4c9ce0fb/main.pdf</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/MAIN/application/pdf/836e2301e26a98d345e8082d4c9ce0fb/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>660994</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>8</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S1569199316300042-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/PREVIEW/image/png/011ff8c9b028a4f858ed5f9ffd9fa8bc/main_1.png</xocs:ucs-locator>
                     <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/PREVIEW/image/png/011ff8c9b028a4f858ed5f9ffd9fa8bc/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>65174</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/gr1/THUMBNAIL/image/gif/6eb85933774917d6adf2e2765a0f2562/gr1.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/gr1/THUMBNAIL/image/gif/6eb85933774917d6adf2e2765a0f2562/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>5760</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>211</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/gr2/THUMBNAIL/image/gif/0e1737aa8500f28b1a15c3662d7fa037/gr2.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/gr2/THUMBNAIL/image/gif/0e1737aa8500f28b1a15c3662d7fa037/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>5061</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>122</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/gr3/THUMBNAIL/image/gif/5d2a129f7c49795f2a2009766007689a/gr3.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/gr3/THUMBNAIL/image/gif/5d2a129f7c49795f2a2009766007689a/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>6022</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>190</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/gr1/DOWNSAMPLED/image/jpeg/9798f95af6a6b15fc347a7e6050f3218/gr1.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/gr1/DOWNSAMPLED/image/jpeg/9798f95af6a6b15fc347a7e6050f3218/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>39633</xocs:filesize>
               <xocs:pixel-height>486</xocs:pixel-height>
               <xocs:pixel-width>627</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/gr2/DOWNSAMPLED/image/jpeg/4ca58a37e6b7295292235c3534c6f002/gr2.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/gr2/DOWNSAMPLED/image/jpeg/4ca58a37e6b7295292235c3534c6f002/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>29732</xocs:filesize>
               <xocs:pixel-height>479</xocs:pixel-height>
               <xocs:pixel-width>359</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/gr3/DOWNSAMPLED/image/jpeg/a6010482587231068baef7ac94cf42d5/gr3.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/gr3/DOWNSAMPLED/image/jpeg/a6010482587231068baef7ac94cf42d5/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>61752</xocs:filesize>
               <xocs:pixel-height>609</xocs:pixel-height>
               <xocs:pixel-width>707</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-gr1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/gr1/HIGHRES/image/jpeg/4c42d5a1ec1289a2bb1e84d668c9f82c/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/gr1/HIGHRES/image/jpeg/4c42d5a1ec1289a2bb1e84d668c9f82c/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>326787</xocs:filesize>
               <xocs:pixel-height>2152</xocs:pixel-height>
               <xocs:pixel-width>2776</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-gr2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/gr2/HIGHRES/image/jpeg/02c1474ce5a1d11b38b1f790b8e59e9e/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/gr2/HIGHRES/image/jpeg/02c1474ce5a1d11b38b1f790b8e59e9e/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>248827</xocs:filesize>
               <xocs:pixel-height>2126</xocs:pixel-height>
               <xocs:pixel-width>1592</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-gr3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/gr3/HIGHRES/image/jpeg/f316374878e0d51ed5ce81de258b57c7/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/gr3/HIGHRES/image/jpeg/f316374878e0d51ed5ce81de258b57c7/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>709473</xocs:filesize>
               <xocs:pixel-height>2695</xocs:pixel-height>
               <xocs:pixel-width>3129</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S1569199316300042-mmc1.doc</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1569199316300042/mmc1/MAIN/application/msword/2a935cca7c3407eb4d88bbe4befb957a/mmc1.doc</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1569199316300042/mmc1/MAIN/application/msword/2a935cca7c3407eb4d88bbe4befb957a/mmc1.doc</xocs:ucs-locator>
               <xocs:file-basename>mmc1</xocs:file-basename>
               <xocs:filename>mmc1.doc</xocs:filename>
               <xocs:extension>doc</xocs:extension>
               <xocs:filesize>54784</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta>
   <xocs:serial-item>
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" version="5.4" docsubtype="fla" xml:lang="en">
         <item-info>
            <jid>JCF</jid>
            <aid>1315</aid>
            <ce:pii>S1569-1993(16)30004-2</ce:pii>
            <ce:doi>10.1016/j.jcf.2016.02.013</ce:doi>
            <ce:copyright type="society" year="2016">European Cystic Fibrosis Society.</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="f0005">
               <ce:label>Fig. 1</ce:label>
               <ce:caption id="ca0005">
                  <ce:simple-para id="sp0005" view="all">Flow chart of the inclusion/exclusion criteria.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0005">Fig. 1</ce:alt-text>
               <ce:link id="lk0005" locator="gr1" xlink:type="simple" xlink:href="pii:S1569199316300042/gr1"/>
            </ce:figure>
            <ce:figure id="f0010">
               <ce:label>Fig. 2</ce:label>
               <ce:caption id="ca0010">
                  <ce:simple-para id="sp0010" view="all">A. Representation of time taken to be tested for relatives.</ce:simple-para>
                  <ce:simple-para id="sp0015" view="all">Time taken to be tested represents the difference between the date of testing and the date of family mutation identification (or the date at adulthood (18<ce:hsp sp="0.25"/>years) for relatives who were minor when the mutation was identified).</ce:simple-para>
                  <ce:simple-para id="sp0020" view="all">B. Representation of age of relatives at testing.</ce:simple-para>
                  <ce:simple-para id="sp0025" view="all">It should be noted that testing was performed before the age of 18<ce:hsp sp="0.25"/>years in 21 relatives, either because CF was suspected in siblings, or because testing was performed before the 1994 French Bioethics Laws that govern genetic testing management and prohibit testing of minor children.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0010">Fig. 2</ce:alt-text>
               <ce:link id="lk0010" locator="gr2" xlink:type="simple" xlink:href="pii:S1569199316300042/gr2"/>
            </ce:figure>
            <ce:figure id="f0015">
               <ce:label>Fig. 3</ce:label>
               <ce:caption id="ca0015">
                  <ce:simple-para id="sp0030" view="all">Overview and public health implications of carrier testing in the 40 participating CF families.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0015">Fig. 3</ce:alt-text>
               <ce:link id="lk0015" locator="gr3" xlink:type="simple" xlink:href="pii:S1569199316300042/gr3"/>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="t0005" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 1</ce:label>
               <ce:caption id="ca0020">
                  <ce:simple-para id="sp0035" view="all">Main features of the CF patients enrolled in the study (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>40) and comparison with the characteristics of the patients born over the same period who did not participate.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0020">Table 1</ce:alt-text>
               <tgroup cols="6">
                  <colspec colname="col1"/>
                  <colspec colname="col2"/>
                  <colspec colname="col3"/>
                  <colspec colname="col4"/>
                  <colspec colname="col5"/>
                  <colspec colname="col6"/>
                  <thead>
                     <row valign="top" rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" colname="col1" align="left">Variables</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col3" align="left" rowsep="1">Enrolled patients</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col4" nameend="col5" align="left" rowsep="1">Non-enrolled patients</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" colname="col6" align="left">
                           <italic>p</italic>
                        </entry>
                     </row>
                     <row valign="top" rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col3" align="left" rowsep="1">n<hsp sp="0.25"/>=<hsp sp="0.25"/>40</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col4" nameend="col5" align="left" rowsep="1">n<hsp sp="0.25"/>=<hsp sp="0.25"/>79</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Gender (n<hsp sp="0.25"/>=<hsp sp="0.25"/>119)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Male</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="left">17</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="left">42.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="left">47</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">59.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" colname="col6" align="char" char=".">0.079</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Female</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="left">23</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="left">57.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="left">32</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">40.5%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Vital status (n<hsp sp="0.25"/>=<hsp sp="0.25"/>119)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Alive</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="left">32</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="left">80.0%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="left">59</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">74.7%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" colname="col6" align="char" char=".">0.518</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Dead</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="left">8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="left">20.0%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="left">20</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">25.3%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Age (years) (n<hsp sp="0.25"/>=<hsp sp="0.25"/>91)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Mean<hsp sp="0.25"/>±<hsp sp="0.25"/>SD</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col3" align="left">20.0<hsp sp="0.10"/>±<hsp sp="0.10"/>6.7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col4" nameend="col5" align="left">21.7<hsp sp="0.10"/>±<hsp sp="0.10"/>7.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">0.274</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Age at death (years) (n<hsp sp="0.25"/>=<hsp sp="0.25"/>28)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col4" nameend="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Mean<hsp sp="0.25"/>±<hsp sp="0.25"/>SD</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col3" align="left">18.3<hsp sp="0.10"/>±<hsp sp="0.10"/>8.3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col4" nameend="col5" align="left">13.2<hsp sp="0.10"/>±<hsp sp="0.10"/>8.9</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">0.172</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Mode of diagnosis (n<hsp sp="0.25"/>=<hsp sp="0.25"/>119)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Clinical symptoms</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="left">18</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="left">45.0%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="left">34</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">43.0%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" colname="col6" align="char" char=".">0.839</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Newborn screening</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="left">22</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="left">55.0%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="left">45</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">57.0%</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="sp0040" view="all">SD: standard deviation.</ce:simple-para>
               </ce:legend>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="t0010" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 2</ce:label>
               <ce:caption id="ca0025">
                  <ce:simple-para id="sp0045" view="all">Main characteristics of the eligible relatives (excluding parents) (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>459).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0025">Table 2</ce:alt-text>
               <tgroup cols="3">
                  <colspec colname="col1"/>
                  <colspec colname="col2"/>
                  <colspec colname="col3"/>
                  <thead>
                     <row valign="top" rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">Characteristics of the eligible relatives (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="left">n</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="left">Frequency</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">Gender of relative (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Male</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">229</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">49.9%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Female</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">230</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">50.1%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">Status of relative at time of mutation identification (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Adult</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">276</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">60.4%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Minor or unborn</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">181</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">39.6%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">Relationship to the CF patient (prior risk) (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Siblings (2/3)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">4.1%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Aunts/uncles (1/2)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">150</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">32.7%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Grandparents (1/2)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">119</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">25.9%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>First cousins (1/4)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">157</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">34.2%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Childs of cousins (1/8)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">3.1%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">Branch (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Nuclear</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">4.1%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Paternal</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">248</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">54.0%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Maternal</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">192</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">41.9%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">Vital status of the CF patient (n<hsp sp="0.25"/>=<hsp sp="0.25"/>457)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Alive</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">374</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">81.8%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Death</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">83</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">18.2%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">Mode of diagnosis of the CF patient (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Clinical symptoms</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">284</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">61.9%</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left">
                           <hsp sp="1"/>Newborn screening</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char=".">175</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">38.1%</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="t0015" frame="topbot" rowsep="0" colsep="0">
               <ce:label>Table 3</ce:label>
               <ce:caption id="ca0030">
                  <ce:simple-para id="sp0050" view="all">Proportion of non-parent relatives tested according to various factors, and results of the univariate and multivariate logistic regression models (adjusted for clustering) searching for predictors of uptake of cascade carrier testing.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="al0030">Table 3</ce:alt-text>
               <tgroup cols="9">
                  <colspec colname="col1"/>
                  <colspec colname="col2"/>
                  <colspec colname="col3"/>
                  <colspec colname="col4"/>
                  <colspec colname="col5"/>
                  <colspec colname="col6"/>
                  <colspec colname="col7"/>
                  <colspec colname="col8"/>
                  <colspec colname="col9"/>
                  <thead>
                     <row valign="bottom" rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1" colname="col1" align="left">Variables</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col3" align="left" rowsep="1">Proportion tested</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col4" nameend="col6" align="left" rowsep="1">Univariate analysis<cross-ref refid="tf0005" id="cf0005">
                              <sup loc="post">⁎</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col7" nameend="col9" align="left" rowsep="1">Mutivariate analysis<cross-ref refid="tf0005" id="cf0010">
                              <sup loc="post">⁎</sup>
                           </cross-ref>
                        </entry>
                     </row>
                     <row valign="bottom" rowsep="1">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="left">n<cross-ref refid="tf0010" id="cf0015">
                              <sup loc="post">⁎⁎</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="left">Frequency</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="left">OR</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">95% CI</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="left">
                           <italic>p</italic>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7" align="left">OR</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8" align="left">95% CI</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9" align="left">
                           <italic>p</italic>
                        </entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Gender of relative (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Female</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">106/230</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">46.1%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">1.64</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">[1.15; 2.32]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">
                           <bold>0.006</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7" align="left">1.52</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8" align="left">[1.04; 2.23]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9" align="char" char=".">
                           <bold>0.031</bold>
                        </entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Male</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">79/229</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">34.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">1.00</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7" align="left">1.00</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Relationship to the CF patient (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Siblings</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">17/19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">89.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">31.62</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">[6.17; 161.97]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">
                           <bold>&lt;<hsp sp="0.10"/>0.001</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Aunts/uncles</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">88/150</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">58.7%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">5.11</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">[2.07; 12.63]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">
                           <bold>&lt;<hsp sp="0.10"/>0.001</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Grandparents</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">46/119</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">38.7%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">2.33</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">[0.90; 6.00]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">0.081</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>First cousins</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">34/157</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">21.7%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">1.00</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Childs of cousins</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">0/14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">0.0%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">
                           <cross-ref refid="tf0015" id="cf0020">
                              <sup loc="post">⁎⁎⁎</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Carrier risk based on relationship to the CF patient (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>2/3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">17/19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">89.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">31.75</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">[6.32; 159.64]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">
                           <bold>&lt;<hsp sp="0.10"/>0.001</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7" align="left">30.13</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8" align="left">[5.74; 158.27]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9" align="char" char=".">
                           <bold>&lt;<hsp sp="0.10"/>0.001</bold>
                        </entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>1/2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">134/269</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">49.8%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">3.68</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">[1.52; 8.89]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">
                           <bold>0.004</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7" align="left">3.61</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8" align="left">[1.48; 8.81]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9" align="char" char=".">
                           <bold>0.005</bold>
                        </entry>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>1/4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">34/157</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">21.7%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">1.00</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7" align="left">1.00</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>1/8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">0/14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">0.0%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">
                           <cross-ref refid="tf0015" id="cf0025">
                              <sup loc="post">⁎⁎⁎</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Branch (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7" align="left">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Nuclear</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">17/19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">89.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">13.32</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">[2.65; 66.94]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">
                           <bold>0.002</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Paternal</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">88/248</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">35.5%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">0.86</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">[0.53; 1.39]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">0.540</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Maternal</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">80/192</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">41.7%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">1.00</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">Mode of diagnosis of the CF patient (n<hsp sp="0.25"/>=<hsp sp="0.25"/>459)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Clinical symptoms</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">112/284</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">39.4%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">0.91</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5" align="left">[0.52; 1.59]</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6" align="char" char=".">0.743</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                     <row valign="bottom">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col1" align="left" role="rowhead">
                           <hsp sp="1"/>Newborn screening</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col2" align="char" char="/">73/175</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col3" align="char" char=".">41.7%</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col4" align="char" char=".">1.00</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col5"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col6"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col7"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col8"/>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" colname="col9"/>
                     </row>
                  </tbody>
               </tgroup>
               <ce:legend>
                  <ce:simple-para id="sp0055" view="all">OR: odds ratio; CI: confidence interval.</ce:simple-para>
               </ce:legend>
               <ce:table-footnote id="tf0005">
                  <ce:label>⁎</ce:label>
                  <ce:note-para id="np0005" view="all">GEE analysis was performed using an exchangeable correlation structure (as it was assumed that all correlations were equal). The “logit” link was used for identification of predictors.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tf0010">
                  <ce:label>⁎⁎</ce:label>
                  <ce:note-para id="np0010" view="all">n: number of eligible relatives tested/number of eligible relatives.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tf0015">
                  <ce:label>⁎⁎⁎</ce:label>
                  <ce:note-para id="np0015" view="all">Odds ratio not estimated due to the very small number of participants in that group.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
         </ce:floats>
         <head>
            <ce:article-footnote>
               <ce:label>☆</ce:label>
               <ce:note-para id="np0020" view="all">Communication: Data presented at the 8th European Cystic Fibrosis Conference, 10–13 June 2015, Brussels, Belgium (oral communication in workshop 11).</ce:note-para>
            </ce:article-footnote>
            <ce:dochead id="dh0005">
               <ce:textfn id="tn0005">Original Article</ce:textfn>
            </ce:dochead>
            <ce:title id="ti0005">Highlighting the impact of cascade carrier testing in cystic fibrosis families</ce:title>
            <ce:author-group id="ag0005">
               <ce:author id="au0005">
                  <ce:indexed-name>Dugueperoux</ce:indexed-name>
                  <ce:given-name>Ingrid</ce:given-name>
                  <ce:surname>Duguépéroux</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0030">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0010" id="cf0035">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0015" id="cf0040">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0005" type="email">ingrid.dugueperoux@univ-brest.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0010">
                  <ce:given-name>Carine</ce:given-name>
                  <ce:surname>L'Hostis</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0045">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0010" id="cf0050">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0015" id="cf0055">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0010" type="email">carine.l-hostis@inserm.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0015">
                  <ce:indexed-name>Audrezet</ce:indexed-name>
                  <ce:given-name>Marie-Pierre</ce:given-name>
                  <ce:surname>Audrézet</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0060">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0010" id="cf0065">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0015" id="cf0070">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0020" id="cf0075">
                     <ce:sup loc="post">d</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0015" type="email">marie-pierre.audrezet@chu-brest.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0020">
                  <ce:given-name>Gilles</ce:given-name>
                  <ce:surname>Rault</ce:surname>
                  <ce:cross-ref refid="af0025" id="cf0080">
                     <ce:sup loc="post">e</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0020" type="email">gilles.rault@perharidy.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0025">
                  <ce:given-name>Irène</ce:given-name>
                  <ce:surname>Frachon</ce:surname>
                  <ce:cross-ref refid="af0030" id="cf0085">
                     <ce:sup loc="post">f</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0025" type="email">irene.frachon@chu-brest.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0030">
                  <ce:given-name>Rémy</ce:given-name>
                  <ce:surname>Bernard</ce:surname>
                  <ce:cross-ref refid="af0035" id="cf0090">
                     <ce:sup loc="post">g</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0030" type="email">r.bernard@ch-cornouaille.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0035">
                  <ce:given-name>Philippe</ce:given-name>
                  <ce:surname>Parent</ce:surname>
                  <ce:cross-ref refid="af0040" id="cf0095">
                     <ce:sup loc="post">h</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0035" type="email">philippe.parent@chu-brest.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0040">
                  <ce:given-name>Martine</ce:given-name>
                  <ce:surname>Blayau</ce:surname>
                  <ce:cross-ref refid="af0045" id="cf0100">
                     <ce:sup loc="post">i</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0040" type="email">martine.blayau@chu-rennes.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0045">
                  <ce:given-name>Sébastien</ce:given-name>
                  <ce:surname>Schmitt</ce:surname>
                  <ce:cross-ref refid="af0050" id="cf0105">
                     <ce:sup loc="post">j</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0045" type="email">sebastien.schmitt@chu-nantes.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0050">
                  <ce:indexed-name>Genin</ce:indexed-name>
                  <ce:given-name>Emmanuelle</ce:given-name>
                  <ce:surname>Génin</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0110">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0010" id="cf0115">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0015" id="cf0120">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0020" id="cf0125">
                     <ce:sup loc="post">d</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0050" type="email">emmanuelle.genin@inserm.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0055">
                  <ce:indexed-name>Ferec</ce:indexed-name>
                  <ce:given-name>Claude</ce:given-name>
                  <ce:surname>Férec</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0130">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0010" id="cf0135">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0015" id="cf0140">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0020" id="cf0145">
                     <ce:sup loc="post">d</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0055" type="email">claude.ferec@univ-brest.fr</ce:e-address>
               </ce:author>
               <ce:author id="au0060">
                  <ce:given-name>Virginie</ce:given-name>
                  <ce:surname>Scotet</ce:surname>
                  <ce:cross-ref refid="af0005" id="cf0150">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0010" id="cf0155">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="af0015" id="cf0160">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cr0005" id="cf0165">
                     <ce:sup loc="post">⁎</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address id="em0060" type="email">virginie.scotet@inserm.fr</ce:e-address>
               </ce:author>
               <ce:affiliation id="af0005">
                  <ce:label>a</ce:label>
                  <ce:textfn id="tn0010">Inserm, UMR 1078, Brest, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Inserm, UMR</sa:organization>
                     <sa:city>Brest</sa:city>
                     <sa:postal-code>1078</sa:postal-code>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0010">
                  <ce:label>b</ce:label>
                  <ce:textfn id="tn0015">Univ. Brest, Brest, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Univ. Brest</sa:organization>
                     <sa:city>Brest</sa:city>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0015">
                  <ce:label>c</ce:label>
                  <ce:textfn id="tn0020">Etablissement Français du Sang-Bretagne, Brest, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Etablissement Français du Sang-Bretagne</sa:organization>
                     <sa:city>Brest</sa:city>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0020">
                  <ce:label>d</ce:label>
                  <ce:textfn id="tn0025">C.H.R.U. Brest, Hôpital Morvan, Laboratoire de Génétique Moléculaire, Brest, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>C.H.R.U. Brest</sa:organization>
                     <sa:organization>Hôpital Morvan</sa:organization>
                     <sa:organization>Laboratoire de Génétique Moléculaire</sa:organization>
                     <sa:city>Brest</sa:city>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0025">
                  <ce:label>e</ce:label>
                  <ce:textfn id="tn0030">Centre de Référence et de Compétences de la Mucoviscidose, Roscoff, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Centre de Référence et de Compétences de la Mucoviscidose</sa:organization>
                     <sa:city>Roscoff</sa:city>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0030">
                  <ce:label>f</ce:label>
                  <ce:textfn id="tn0035">C.H.R.U. Brest, Hôpital Cavale Blanche, Service de Pneumologie, Brest, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>C.H.R.U. Brest</sa:organization>
                     <sa:organization>Hôpital Cavale Blanche</sa:organization>
                     <sa:organization>Service de Pneumologie</sa:organization>
                     <sa:city>Brest</sa:city>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0035">
                  <ce:label>g</ce:label>
                  <ce:textfn id="tn0040">C.H.I.C. Quimper, Service de Pneumologie, Quimper, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>C.H.I.C. Quimper</sa:organization>
                     <sa:organization>Service de Pneumologie</sa:organization>
                     <sa:city>Quimper</sa:city>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0040">
                  <ce:label>h</ce:label>
                  <ce:textfn id="tn0045">C.H.R.U. Brest, Hôpital Morvan, Service de Pédiatrie et de Génétique Médicale, Brest, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>C.H.R.U. Brest</sa:organization>
                     <sa:organization>Hôpital Morvan</sa:organization>
                     <sa:organization>Service de Pédiatrie et de Génétique Médicale</sa:organization>
                     <sa:city>Brest</sa:city>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0045">
                  <ce:label>i</ce:label>
                  <ce:textfn id="tn0050">C.H.R.U. Rennes, Laboratoire de Génétique Moléculaire, Rennes, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>C.H.R.U. Rennes</sa:organization>
                     <sa:organization>Laboratoire de Génétique Moléculaire</sa:organization>
                     <sa:city>Rennes</sa:city>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="af0050">
                  <ce:label>j</ce:label>
                  <ce:textfn id="tn0055">C.H.R.U. Nantes, Laboratoire de Génétique Moléculaire, Nantes, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>C.H.R.U. Nantes</sa:organization>
                     <sa:organization>Laboratoire de Génétique Moléculaire</sa:organization>
                     <sa:city>Nantes</sa:city>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:correspondence id="cr0005">
                  <ce:label>⁎</ce:label>
                  <ce:text id="tx0005">Corresponding author at: Inserm UMR 1078 Génétique, Génomique et Biotechnologies, 46 rue Félix Le Dantec, CS 51819, 29218 Brest Cedex 2, France. Tel.: +<ce:hsp sp="0.10"/>33 2 98 44 41 38; fax: +<ce:hsp sp="0.10"/>33 2 98 43 05 55.</ce:text>
                  <sa:affiliation>
                     <sa:organization>Inserm UMR 1078 Génétique</sa:organization>
                     <sa:organization>Génomique et Biotechnologies</sa:organization>
                     <sa:address-line>46 rue Félix Le Dantec</sa:address-line>
                     <sa:address-line>CS 51819</sa:address-line>
                     <sa:city>Brest Cedex 2</sa:city>
                     <sa:postal-code>29218</sa:postal-code>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:correspondence>
            </ce:author-group>
            <ce:date-received day="7" month="12" year="2015"/>
            <ce:date-revised day="10" month="2" year="2016"/>
            <ce:date-accepted day="28" month="2" year="2016"/>
            <ce:abstract id="ab0005" xml:lang="en" view="all" class="author">
               <ce:section-title id="st0005">Abstract</ce:section-title>
               <ce:abstract-sec id="as0005" view="all">
                  <ce:section-title id="st0010">Background</ce:section-title>
                  <ce:simple-para id="sp0060" view="all">Cascade carrier testing within cystic fibrosis (CF) affected families offers relatives of CF patients the opportunity to know their status regarding the mutation that segregates within their family, and thus to make informed reproductive choices. As an Australian study has recently shown that this test seemed underused, we searched to assess uptake of this test in a European area where CF is common, and to report its public health implications.</ce:simple-para>
               </ce:abstract-sec>
               <ce:abstract-sec id="as0010" view="all">
                  <ce:section-title id="st0015">Methods</ce:section-title>
                  <ce:simple-para id="sp0065" view="all">This study relied on 40 CF-affected families from western Brittany, France. Investigations included drawing of family trees and registration of carrier tests performed in those families.</ce:simple-para>
               </ce:abstract-sec>
               <ce:abstract-sec id="as0015" view="all">
                  <ce:section-title id="st0020">Results</ce:section-title>
                  <ce:simple-para id="sp0070" view="all">Of the 459 relatives eligible for testing, 185 were tested, leading to an adjusted uptake rate of testing of 40.7% (95% CI: [34.1%; 47.3%]). The main predictors for having testing were being female (p<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.031) and having a high prior risk (p<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001). Planning a pregnancy or expecting a child (reported in at least 38.4% of tested relatives) also appeared critical in choosing to be tested. Overall, carrier testing allowed to reassure more than 1/4 of the relatives and to detect five new 1-in-4 at-risk couples who then requested prenatal diagnosis.</ce:simple-para>
               </ce:abstract-sec>
               <ce:abstract-sec id="as0020" view="all">
                  <ce:section-title id="st0025">Conclusions</ce:section-title>
                  <ce:simple-para id="sp0075" view="all">This observational study assesses, for first time in Europe, uptake of CF cascade carrier testing within CF families, which is a critical tool to reassure non-carriers and to detect early new at-risk couples.</ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            <ce:keywords class="abr" id="ks0005" view="all">
               <ce:section-title id="st0030">Abbreviations</ce:section-title>
               <ce:keyword id="kw0005">
                  <ce:text id="tx0010">OR</ce:text>
                  <ce:keyword id="kw0010">
                     <ce:text id="tx0015">odds ratio</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kw0015">
                  <ce:text id="tx0020">95% CI</ce:text>
                  <ce:keyword id="kw0020">
                     <ce:text id="tx0025">95% confidence interval</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kw0025">
                  <ce:text id="tx0030">GEE</ce:text>
                  <ce:keyword id="kw0030">
                     <ce:text id="tx0035">generalized estimating equations</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kw0035">
                  <ce:text id="tx0040">NBS</ce:text>
                  <ce:keyword id="kw0040">
                     <ce:text id="tx0045">newborn screening</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kw0045">
                  <ce:text id="tx0050">SD</ce:text>
                  <ce:keyword id="kw0050">
                     <ce:text id="tx0055">standard deviation</ce:text>
                  </ce:keyword>
               </ce:keyword>
            </ce:keywords>
            <ce:keywords id="ks0010" view="all" class="keyword">
               <ce:section-title id="st0035">Keywords</ce:section-title>
               <ce:keyword id="kw0055">
                  <ce:text id="tx0060">Cystic fibrosis</ce:text>
               </ce:keyword>
               <ce:keyword id="kw0060">
                  <ce:text id="tx0065">
                     <ce:italic>CFTR</ce:italic>
                  </ce:text>
               </ce:keyword>
               <ce:keyword id="kw0065">
                  <ce:text id="tx0070">Cascade carrier testing</ce:text>
               </ce:keyword>
               <ce:keyword id="kw0070">
                  <ce:text id="tx0075">Genetic counseling</ce:text>
               </ce:keyword>
               <ce:keyword id="kw0075">
                  <ce:text id="tx0080">Predictors</ce:text>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="s0005" view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title id="st0040">Introduction</ce:section-title>
                  <ce:para id="p0005" view="all">Despite great improvements in disease management that allow more than half the patients to reach adulthood, cystic fibrosis (CF) remains a life-threatening condition <ce:cross-ref id="cf0170" refid="bb0005">[1]</ce:cross-ref>. The identification in 1989 of the gene responsible for this autosomal recessive disease (the <ce:italic>Cystic Fibrosis Transmembrane conductance Regulator</ce:italic> (<ce:italic>CFTR</ce:italic>) <ce:italic>gene</ce:italic>) <ce:cross-refs id="cf0175" refid="bb0010 bb0015 bb0020">[2–4]</ce:cross-refs> made possible genetic diagnosis for CF patients, and thus cascade carrier testing for family members.</ce:para>
                  <ce:para id="p0010" view="all">Cascade carrier testing offers relatives of CF patients (who have an increased risk of being themselves carriers of the mutation that segregates within their family) the opportunity to know their status regarding the family mutation. The term “cascade” reflects the fact that the test stems from an index case: it is first offered to the relatives of the CF patient and, in a second time, to their spouses if the relatives are found carrier. The ultimate goal of this test is to reassure non-carrier relatives, but also to allow for early detection of couples with a 1-in-4 risk of having a CF child, who will then be able to make informed reproductive choices (such as use of prenatal diagnosis). In the absence of mutation-specific therapy for all patients, cascade carrier testing within families remains therefore a major prevention tool in the context of serious genetic diseases <ce:cross-refs id="cf0180" refid="bb0025 bb0030 bb0035 bb0040">[5–8]</ce:cross-refs>.</ce:para>
                  <ce:para id="p0015" view="all">Cascade carrier testing should not be confused with population-based carrier screening that aims to identify all CF carriers in a given population. Such programs are undertaken in some regions around the world, as in Australia, in the Veneto region in Italy or in the US <ce:cross-refs id="cf0185" refid="bb0045 bb0050 bb0055">[9–11]</ce:cross-refs>.</ce:para>
                  <ce:para id="p0020" view="all">To date, few studies have been published on cascade carrier testing within CF families <ce:cross-refs id="cf0190" refid="bb0060 bb0065 bb0070 bb0075 bb0080 bb0085 bb0090">[12–18]</ce:cross-refs>, and most of them reported results of active programs (in regard to information or recruitment of relatives). Globally, relatively low rates of testing uptake have been observed in relatives of affected patients. In an observational study conducted in Victoria (Australia) in 2010, McClaren et al. <ce:cross-ref id="cf0195" refid="bb0090">[18]</ce:cross-ref> reported an uptake rate of testing of 11.8% in relatives of screened children born during 2000–2004. To our knowledge, no measure of uptake of cascade carrier testing in CF families has been performed in France or in Europe, from an observational study design based on the examination of clinical practices.</ce:para>
                  <ce:para id="p0025" view="all">The present study aims to assess the uptake of cascade carrier testing in relatives of CF patients born over a 25-year period (1980–2004) in a district of western Brittany (Finistère, France), where CF is particularly common <ce:cross-ref id="cf0200" refid="bb0095">[19]</ce:cross-ref>. It determines the proportion of relatives tested, identifies factors influencing the choice of having testing, and reports the public health implications of this test.</ce:para>
               </ce:section>
               <ce:section id="s0010" view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title id="st0045">Population and methods</ce:section-title>
                  <ce:section id="s0015" view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title id="st0050">Study design and setting</ce:section-title>
                     <ce:para id="p0030" view="all">We conducted an observational retrospective study in the district of Finistère, an area of 900,000 inhabitants in western Brittany (France) where the incidence of CF is high (~<ce:hsp sp="0.10"/>1/2500 live births) <ce:cross-refs id="cf0205" refid="bb0095 bb0100">[19,20]</ce:cross-refs>. The high mutation detection rate obtained in that population shortly after the discovery of the <ce:italic>CFTR</ce:italic> gene <ce:cross-ref id="cf0210" refid="bb0105">[21]</ce:cross-ref> has enabled clinicians to offer early an efficient and efficacious testing process to identify carriers in CF families.</ce:para>
                     <ce:para id="p0035" view="all">When CF is diagnosed in a child, his parents have the opportunity to meet a genetic counselor, who explains the disease, but also the implications of the diagnosis for future pregnancies and the availability of cascade carrier testing for their relatives. As until recently the transmission of the genetic information within families could exclusively be done by the parents of the CF child, they were invited to inform their relatives about their possibility of having testing. A recent change in French law henceforth allows GPs to directly inform relatives of CF patients on their risk and the possibility of getting tested.</ce:para>
                     <ce:para id="p0040" view="all">Cascade carrier testing, which is offered during a genetic counseling session, consists first in determining whether the relative does or not carry the <ce:italic>CFTR</ce:italic> mutation that segregates within his/her family. If the relative appears to be non-carrier of this mutation, the study is stopped and he/she can be reassured regarding his/her offspring. Conversely, if the relative is found to be carrier, a <ce:italic>CFTR</ce:italic> gene analysis is proposed to his/her spouse. The guidelines are to use of a commercial kit (of 30 mutations) that enables to detect 85% of the <ce:italic>CFTR</ce:italic> mutations in the French population. If no mutation is identified in the spouse by this strategy, a residual risk of CF is given to the couple. On the other hand, if one mutation is also identified in the partner, the couple has a 1-in-4 risk of having a CF child. Genetic counseling is then offered to the couple who may opt for prenatal diagnosis for current or future pregnancies. Such tests are covered by the French Health Insurance.</ce:para>
                  </ce:section>
                  <ce:section id="s0020" view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title id="st0055">Study population</ce:section-title>
                     <ce:para id="p0045" view="all">This study was conducted from families of CF patients born in Finistère over the 1980–2004 period. It was approved by the ethical committee of the University Hospital of Brest.</ce:para>
                     <ce:para id="p0050" view="all">The identification of patients eligible for the study was facilitated because a registry of CF patients born in Brittany since the 1970s was set up several years ago <ce:cross-ref id="cf0215" refid="bb0095">[19]</ce:cross-ref>, and because Brittany was a pioneer back in 1989 in setting up a CF newborn screening (NBS) program <ce:cross-ref id="cf0220" refid="bb0110">[22]</ce:cross-ref>.</ce:para>
                     <ce:para id="p0055" view="all">The flow chart of the inclusion/exclusion criteria in the study is presented in <ce:cross-ref id="cf0225" refid="f0005">Fig. 1</ce:cross-ref>
                        <ce:float-anchor refid="f0005"/>. Over the study period, 128 CF patients were born in the district of Finistère. Nine of them were <ce:italic>de facto</ce:italic> ineligible for the study: two were adopted and seven already had a CF-affected sibling born during the study period (only one patient per family, the first diagnosed, could be included). In all, 119 patients were eligible for the study, but only 109 could be informed of the study as eight were lost to follow up and two had a difficult family context. At the end of the inclusion period (Dec. 31st, 2014), 40 families agreed to participate in the study.</ce:para>
                  </ce:section>
                  <ce:section id="s0025" view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title id="st0060">Data collection and management</ce:section-title>
                     <ce:para id="p0060" view="all">A two-step strategy was used to collect data required for the study:<ce:list id="l0005">
                           <ce:list-item id="o0005">
                              <ce:label>1)</ce:label>
                              <ce:para id="p0065" view="all">First, patients (or their parents) were asked to fill out a consent form and to provide a family tree (limited to all descendants and spouses of the grandparents of the enrolled CF patient) that was reconstructed using the GenoPro® software (v. 2.0.1.6).</ce:para>
                           </ce:list-item>
                           <ce:list-item id="o0010">
                              <ce:label>2)</ce:label>
                              <ce:para id="p0070" view="all">Thereafter, we collected results of all the <ce:italic>CFTR</ce:italic> gene studies performed in those families from the three molecular genetics laboratories of Brittany (University Hospitals of Brest, Rennes and Nantes) and from the medical genetics unit at the Hospital of Brest.</ce:para>
                           </ce:list-item>
                        </ce:list>
                     </ce:para>
                     <ce:para id="p0075" view="all">Both data sources (family structures and gene testing results) were then compared.</ce:para>
                  </ce:section>
                  <ce:section id="s0030" view="all">
                     <ce:label>2.4</ce:label>
                     <ce:section-title id="st0065">Statistical analysis</ce:section-title>
                     <ce:para id="p0080" view="all">Statistical analyses were performed using SAS® software (v. 9.2) and the significance level was set at 5%.</ce:para>
                     <ce:para id="p0085" view="all">First, we described the characteristics of the patients who participated in the study and assessed the sample representativeness. We then described the family structure and the relatives' characteristics, and estimated the frequency of uptake of carrier testing (with its 95% confidence interval [CI]). This frequency corresponded to the proportion of relatives tested among the eligible ones. To be eligible for testing, relatives had to be 18<ce:hsp sp="0.25"/>years or older at the time of the family's entry into the study, to be alive at the time of molecular diagnosis of the CF patient, to reside in one of the four districts of Brittany (Finistère, Côtes-d'Armor, Morbihan and Ille-et-Vilaine), and not prenatally tested (Supplementary material 1). Afterwards, we searched for the predictors of uptake of testing and investigated, using logistic regression, the association between the status of eligible relatives (tested versus untested) and various factors (such as gender, degree of kinship, etc.). Crude and adjusted odds ratios (OR) with their 95% CI were estimated. We also studied the time taken to complete the test, as well as the age of relatives when tested. Finally, we assessed the public health impact of carrier testing within families by determining the number of relatives/couples reassured, the number of relatives identified as carrying the family mutation, the number of 1-in-4 at risk couples detected, the number of prenatal diagnoses subsequently performed, the number of CF-fetuses identified, and the number of medical pregnancy terminations performed afterwards.</ce:para>
                     <ce:para id="p0090" view="all">It is important to note that parents were excluded from most analyses because they are obligate carriers who usually choose to be tested. Moreover, estimation of uptake rate and search for predictors were conducted using generalized estimating equations (GEE) <ce:cross-refs id="cf0230" refid="bb0090 bb0115">[18,23]</ce:cross-refs> that took into account clustering/correlation within families (i.e., the fact that an individual belonging to a family in which many relatives have been tested is himself more likely to request testing).</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="s0035" view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title id="st0070">Results</ce:section-title>
                  <ce:section id="s0040" view="all">
                     <ce:label>3.1</ce:label>
                     <ce:section-title id="st0075">Description of enrolled patients</ce:section-title>
                     <ce:para id="p0095" view="all">Our study was carried out from 40 patients whose baseline characteristics are summarized in <ce:cross-ref id="cf0235" refid="t0005">Table 1</ce:cross-ref>
                        <ce:float-anchor refid="t0005"/>. Of them, 23 (57.5%) were females and 32 (80.0%) were alive at the time of inclusion with a mean age of 20.0<ce:hsp sp="0.25"/>years (SD<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>6.7). All patients had two severe CF-causing mutations, except one who carried a mild mutation (p.Arg347His) (Supplementary material 2). Globally, the CF patients who participated in the study (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>40) did not differ from those who did not (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>79).</ce:para>
                  </ce:section>
                  <ce:section id="s0045" view="all">
                     <ce:label>3.2</ce:label>
                     <ce:section-title id="st0080">Description of enrolled families</ce:section-title>
                     <ce:para id="p0100" view="all">The 40 participating families represented a total of 1301 individuals, including 80 parents, 955 relatives, 3 non-genetic relatives (adoptions) and 263 spouses. The mean number of relatives per family was 23.9 (range: [5; 62]).</ce:para>
                     <ce:para id="p0105" view="all">Among the 955 relatives (excluding parents), 459 (48.1%) were found eligible for testing (i.e., 11.5 per family). Their characteristics are summarized in <ce:cross-ref id="cf0240" refid="t0010">Table 2</ce:cross-ref>
                        <ce:float-anchor refid="t0010"/>. Among them, 58.6% had a 1/2 prior risk of being a carrier (i.e., uncles, aunts or grandparents, n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>269), 34.2% had a 1/4 prior risk (i.e., cousins, n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>157), 4.1% a 2/3 prior risk (i.e., siblings, n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>19), and finally, 3.1% a 1/8 prior risk (i.e., children of cousins, n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>14).</ce:para>
                     <ce:para id="p0110" view="all">The main reason for ineligibility was being under 18<ce:hsp sp="0.25"/>years at the time of inclusion (68.1%).</ce:para>
                  </ce:section>
                  <ce:section id="s0050" view="all">
                     <ce:label>3.3</ce:label>
                     <ce:section-title id="st0085">Assessment of uptake of cascade carrier testing</ce:section-title>
                     <ce:para id="p0115" view="all">Among the 459 eligible relatives, 185 (40.3%) chose to do the test, what corresponds, on average, to 4.6 relatives tested per family. The uptake rate of testing varies from one family to another, and ranged from 0.0% (in four families) to 92.3%. When adjusting for family effect, the uptake rate of testing was estimated at 40.7% (95% CI: [34.1%; 47.3%]), and raised to 48.8% (95% CI: [42.7%; 54.8%]) when taking into account the parents.</ce:para>
                  </ce:section>
                  <ce:section id="s0055" view="all">
                     <ce:label>3.4</ce:label>
                     <ce:section-title id="st0090">Predictors of uptake of cascade carrier testing</ce:section-title>
                     <ce:para id="p0120" view="all">We then aimed at identifying the predictors of uptake of testing. <ce:cross-ref id="cf0245" refid="t0015">Table 3</ce:cross-ref>
                        <ce:float-anchor refid="t0015"/> shows that the uptake of testing was mainly determined by female gender and by having a high prior risk of being carrier of the family mutation. Indeed, the uptake rate was 1.5 times higher in women than men (46.1% vs. 34.5% - adjusted OR<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>1.52; 95% CI: [1.04; 2.23]; p<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.031). It also increased with the degree of kinship, from 21.7% in first cousins to 89.5% in siblings. Overall, compared with relatives having a 1/4 prior risk, the uptake rate was 30.1 times higher in relatives with a 2/3 prior risk (p<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001), and 3.6 times higher in relatives with a 1/2 prior risk (p<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.005). It is also important to note that close to 40% (71/185) of the eligible relatives who were tested, declared having a planned or an ongoing pregnancy at time of testing.</ce:para>
                  </ce:section>
                  <ce:section id="s0060" view="all">
                     <ce:label>3.5</ce:label>
                     <ce:section-title id="st0095">Time taken to perform the test and age at testing</ce:section-title>
                     <ce:section id="s0065" view="all">
                        <ce:label>3.5.1</ce:label>
                        <ce:section-title id="st0100">Time taken to perform the test (<ce:cross-ref id="cf0250" refid="f0010">Fig. 2</ce:cross-ref>a)</ce:section-title>
                        <ce:para id="p0125" view="all">
                           <ce:float-anchor refid="f0010"/>Most of eligible relatives (excluding parents) did the test shortly after the identification of the family mutation (45.0% within the first year). Overall, the median time taken to complete the test was 1.4<ce:hsp sp="0.25"/>years (interquartile range: [0.3; 6.2]).</ce:para>
                     </ce:section>
                     <ce:section id="s0070" view="all">
                        <ce:label>3.5.2</ce:label>
                        <ce:section-title id="st0105">Age of eligible relatives at time of testing (<ce:cross-ref id="cf0255" refid="f0010">Fig. 2</ce:cross-ref>b)</ce:section-title>
                        <ce:para id="p0130" view="all">The median age at testing was 31.2<ce:hsp sp="0.25"/>years (interquartile range: [25.1; 47.0]). Two peaks were nevertheless observed: one in the 25–35 age group (44.4%), which includes the average age at first child, and another one in the 45–55 age group (17.2%), corresponding to post-reproductive ages, where the knowledge of the genetic status may be more useful to offspring.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="s0075" view="all">
                     <ce:label>3.6</ce:label>
                     <ce:section-title id="st0110">Public health implications of cascade carrier testing</ce:section-title>
                     <ce:para id="p0135" view="all">Finally, we reported the impact of cascade carrier testing within the studied families (<ce:cross-ref id="cf0260" refid="f0015">Fig. 3</ce:cross-ref>
                        <ce:float-anchor refid="f0015"/>). Among the 185 relatives tested, 98 (53.0%) were identified carriers of the family mutation. Among their tested partners (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>65), five were also found carriers of one <ce:italic>CFTR</ce:italic> mutation, resulting in the identification of five new 1-in-4 at risk couples within these families. These couples benefited from prenatal diagnosis for eight subsequent pregnancies; five CF-affected fetuses were found and pregnancies terminated.</ce:para>
                     <ce:para id="p0140" view="all">Moreover, cascade carrier testing made it possible to give reassurance to 87 tested relatives (who were shown to be non-carriers of the family mutation), and 60 couples (for whom the spouse of the carrier relatives was negative). In addition, 160 other relatives who were not tested (40 eligible and 120 ineligible) could be deduced non-carriers of the family mutation based on the information obtained from tested relatives. Indeed, the descendants of an individual who was found to be a non-carrier of the family mutation are <ce:italic>de facto</ce:italic> non-carriers of that mutation, and may be reassured regarding that mutation. Overall cascade carrier testing showed that over a quarter of the relatives were non-carriers of the family mutation (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>247, 25.9%): one-third through testing (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>87, 35.2%) and two-thirds by inference (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>160, 64.8%).</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="s0080" view="all">
                  <ce:label>4</ce:label>
                  <ce:section-title id="st0115">Discussion</ce:section-title>
                  <ce:para id="p0145" view="all">This observational study reports the first experience of one European area regarding uptake of cascade carrier testing within CF families. It shows a particularly high rate of test uptake in relatives of patients born in western Brittany over a 25-year period (40.7%). The public health impact of cascade carrier testing was also studied and we found that, besides the identification of numerous carriers and the detection of five new 1-in-4 at risk couples, the test was also useful at reassuring about one quarter of the relatives who were non-carrier of the family mutation. Furthermore, this study confirms that women and relatives with higher prior risks are more inclined to have testing. It also shows that having a planned or an ongoing pregnancy is a key element in making the decision to make the test. This is consistent with the observed median age at testing (31.2<ce:hsp sp="0.25"/>years), which is close to the average age at first child in France (28.8<ce:hsp sp="0.25"/>years in 2013 — <ce:inter-ref id="ir0005" xlink:href="http://www.insee.fr" xlink:type="simple">http://www.insee.fr</ce:inter-ref>). It should have been great to assess if the severity of the genotype in the CF-affected member may had an influence on the uptake rate. Unfortunately, this was not feasible in our study as among the 40 enrolled CF patients, only one was carrier of a mild <ce:italic>CFTR</ce:italic> genotype.</ce:para>
                  <ce:para id="p0150" view="all">Our study also reveals that the uptake rate of testing is particularly high among grandparents (38.7%), who are a key point in the genealogical structure. Knowing their genetic status can allow them to share this information with their own siblings/offspring who may be reassured when they are found non-carriers. This avoids numerous testing in the progeny.</ce:para>
                  <ce:para id="p0155" view="all">Western Brittany is an ideal place in which to conduct this survey because CF is particularly common in this area <ce:cross-ref id="cf0265" refid="bb0095">[19]</ce:cross-ref>. A NBS program has been in place for over 25<ce:hsp sp="0.25"/>years <ce:cross-ref id="cf0270" refid="bb0110">[22]</ce:cross-ref>, and since 1992, a very high <ce:italic>CFTR</ce:italic> mutation detection rate (&gt;<ce:hsp sp="0.10"/>98%) was reached in that population <ce:cross-ref id="cf0275" refid="bb0105">[21]</ce:cross-ref> facilitating early the possibility of efficient cascade carrier testing for families in our region. Moreover, its population is particularly aware of CF and mobilized against it since the early 1990s. All this contributes to explain the high uptake rate we observed.</ce:para>
                  <ce:para id="p0160" view="all">Regarding sample size, our study relied on a non-neglect number of families (40 versus 30 in the Australian study) and we ensured that the enrolled patients were representative of the target population. As our study was performed on a panel of families, it was not possible to measure the overall impact of cascade carrier testing on the disease incidence over the studied period. This was nevertheless already assessed by our team in a previous study devoted to prenatal diagnosis, which highlighted that ~<ce:hsp sp="0.10"/>1/5 of prenatal diagnoses were consecutive to cascade carrier testing <ce:cross-ref id="cf0280" refid="bb0120">[24]</ce:cross-ref>. It is important to keep in mind that, if this test was initially offered to relatives of CF patients, it could thereafter be proposed to relatives of carriers identified through NBS programs <ce:cross-ref id="cf0285" refid="bb0125">[25]</ce:cross-ref>.</ce:para>
                  <ce:para id="p0165" view="all">A weakness of our study was our inability to involve all the French genetic laboratories (both public and private, n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>36), and therefore have information on test status for all the relatives. Beyond the genetic laboratory of Finistère (which has great expertise in CF and is one of the four reference laboratories for the French CF NBS program), we had access to data from the two other genetic laboratories in the Brittany area. To overcome a possible bias, the relatives who lived outside of Brittany were excluded from the calculations (they represented only a small proportion (~<ce:hsp sp="0.10"/>20%) of the non-eligible relatives).</ce:para>
                  <ce:para id="p0170" view="all">Cascade carrier testing is effective in other genetic disorders such as Huntington's disease, beta-thalassemia, Duchenne muscular dystrophy or fragile X syndrome <ce:cross-refs id="cf0290" refid="bb0030 bb0040 bb0130">[6,8,26]</ce:cross-refs>, but it appears that the majority of at-risk family members do not have genetic testing <ce:cross-ref id="cf0295" refid="bb0130">[26]</ce:cross-ref>. In CF, the first experience regarding cascade carrier testing was reported in 1993 by Turner et al. <ce:cross-ref id="cf0300" refid="bb0060">[12]</ce:cross-ref>, who described the tests performed in an extended Australian family (estimated uptake rate: 21.2%). One year later, Super et al. <ce:cross-ref id="cf0305" refid="bb0065">[13]</ce:cross-ref> reported the acceptability and efficiency of active screening for carriers in more than 600 British CF families. They found an increase in the number of tests performed following the start of an active information program, but the study design made it impossible to estimate the uptake rate.</ce:para>
                  <ce:para id="p0175" view="all">Several studies have focused on the uptake of cascade carrier testing, but they were mainly based on active information or recruitment strategies <ce:cross-refs id="cf0310" refid="bb0060 bb0075 bb0080 bb0085">[12,15–17]</ce:cross-refs>. Moreover, these studies relied on heterogeneous designs, including various populations (relatives only, relatives and partners, various degrees relatives, etc) contacted in different ways (letter, phone call, educational courses, etc). The uptake rate was clearly higher in studies based on active programs (from ~<ce:hsp sp="0.10"/>20 to ~<ce:hsp sp="0.10"/>70%) <ce:cross-refs id="cf0315" refid="bb0060 bb0075 bb0080 bb0085">[12,15–17]</ce:cross-refs> than in observational ones (~<ce:hsp sp="0.10"/>10%) <ce:cross-refs id="cf0320" refid="bb0070 bb0090">[14,18]</ce:cross-refs>.</ce:para>
                  <ce:para id="p0180" view="all">Similar to the Australian study by McClaren et al. <ce:cross-ref id="cf0325" refid="bb0090">[18]</ce:cross-ref> (carried out from patients screened at birth in Victoria from 2000 to 2004) and the Canadian one by Surh et al. <ce:cross-ref id="cf0330" refid="bb0070">[14]</ce:cross-ref> (conduced in Ottawa from 1990 to 1992), our study is an observational study based on the examination of clinical practices, without any interventional policy. However, we found an uptake rate higher than those previously reported (40.7% versus<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>12% in Victoria and Ottawa). This difference can mainly be explained by divergences in family structures (families less extended in our study, leading to greater proportions of relatives with high prior risk), study durations (our study was longer and therefore allows a greater proportion of siblings with high prior risk to be eligible for testing) and in population awareness. Even though uptake rates were different, the uptake predictors we found were consistent with those reported by the Australian team (with similar odds ratios) <ce:cross-ref id="cf0335" refid="bb0090">[18]</ce:cross-ref>. The fact that women are more inclined to make the test corroborates the gender effect found in other genetic disorders <ce:cross-refs id="cf0340" refid="bb0130 bb0135 bb0140 bb0145">[26–29]</ce:cross-refs>.</ce:para>
                  <ce:para id="p0185" view="all">Regarding sociological aspects, several authors have noted that, in relatives, disease knowledge levels <ce:cross-ref id="cf0345" refid="bb0150">[30]</ce:cross-ref>, perceived genetic risk and perceived burden of having a CF child are highly relevant at the time of making the decision to be tested <ce:cross-refs id="cf0350" refid="bb0075 bb0155 bb0160">[15,31,32]</ce:cross-refs>. It is also essential to emphasize the importance of the dissemination of genetic information within families. Information and testing enable early detection of potential new 1-in-4 at risk couples, but above all, provide reassurance to non-carrier relatives and their offspring. This avoids realization of unnecessary genetic tests. The role of patients is substantial, as they are the first stage in the transmission of genetic information to relatives. Communication should certainly be easier since set up of NBS programs and multidisciplinary disease management in CF centers. The need to provide support to parents to facilitate the information transmission appears crucial <ce:cross-ref id="cf0355" refid="bb0165">[33]</ce:cross-ref>. Recent changes in French laws that now allow GPs to inform relatives of CF patients might have an impact on the uptake rate of testing in the coming years.</ce:para>
                  <ce:para id="p0190" view="all">After testing, couples for whom both members are found carriers have to cope with the impact of such a result on their reproductive behavior. In the late 1990s, Henneman et al. <ce:cross-ref id="cf0360" refid="bb0170">[34]</ce:cross-ref> showed that most couples report shock, more anxiety (especially when pregnancy is ongoing) and difficulties in disclosing the results to family members. However, most couples did not regret the choice to have testing. It would be interesting to reassess if such perceptions have changed over the years.</ce:para>
                  <ce:para id="p0195" view="all">Investigating the reasons for not testing in relatives of 30 CF children diagnosed through newborn screening, McClaren et al. <ce:cross-ref id="cf0365" refid="bb0165">[33]</ce:cross-ref> recently showed that the main reasons mentioned by relatives are irrelevant perception of the test's usefulness, lack of awareness of the possibility to do the test and test considered as something to do later.</ce:para>
                  <ce:para id="p0200" view="all">In conclusion, this study provides an overview of the uptake of cascade carrier testing in CF families in western Brittany. It also highlights the public health implications of this test, which is a useful tool to reassure relatives/couples and for early detection of new at-risk couples. Further sociological studies are needed to more finely investigate motivations and reluctance to do the test. Besides CF, this study provides some important insights on the population acceptability of genetic testing in general that could be useful for making decisions regarding the release of incidental findings when next-generation sequencing studies are performed.</ce:para>
               </ce:section>
               <ce:section id="s0085" view="all">
                  <ce:section-title id="st0120">Conflicts of interest</ce:section-title>
                  <ce:para id="p0205" view="all">None.</ce:para>
               </ce:section>
            </ce:sections>
            <ce:acknowledgment id="ac0005" view="all">
               <ce:section-title id="st0125">Acknowledgments</ce:section-title>
               <ce:para id="p0210" view="all">We thank all the patients and families who participated in this study, as well as the teams and physicians from the CF centers who contributed data: Drs. A. Dirou, J. Le Bihan, S. Ramel, G. Rault and K. Revert (Roscoff), Drs. MR. Munck and I. Frachon (Brest), Drs. R. Bernard and P. Vic (Quimper), Dr. R. Chiron (Montpellier), Dr. A. Dumonceaux (Ile de la Réunion), Dr. A. Houzel (Dijon) and Dr. C. Thumerelle (Lille). We also thank B.J. McClaren and O.C. Ukoumunne from the Murdoch Childrens Research Institute in Victoria, Australia for their invaluable help with GEE analysis.</ce:para>
               <ce:para id="p0215" view="all">This study was funded by a grant from the <ce:grant-sponsor id="gts0005" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">French CF Association</ce:grant-sponsor> “Vaincre La Mucoviscidose” (<ce:grant-number id="gtn0005" refid="gts0005">RC20120600694</ce:grant-number> and <ce:grant-number id="gtn0010" refid="gts0005">RC20130500859</ce:grant-number>) and by the Association <ce:grant-sponsor id="gts0010" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Gaëtan Saleün</ce:grant-sponsor> “Don du Sang et Recherche en Génétique”. The funders have no role in data analysis, interpretation or in the writing of the manuscript.</ce:para>
            </ce:acknowledgment>
            <ce:appendices view="all">
               <ce:section id="s0090" view="extended">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="st0130">Supplementary data</ce:section-title>
                  <ce:para id="p0220" view="all">
                     <ce:display>
                        <ce:e-component id="ec0005">
                           <ce:caption id="ca0035">
                              <ce:simple-para id="sp0080" view="all">Supplementary materials</ce:simple-para>
                           </ce:caption>
                           <ce:alt-text role="short" id="al0035">Image 1</ce:alt-text>
                           <ce:link id="lk0020" locator="mmc1" xlink:type="simple" xlink:href="pii:S1569199316300042/mmc1"/>
                        </ce:e-component>
                     </ce:display>
                  </ce:para>
               </ce:section>
               <ce:section view="compact-standard" id="s0095">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="st0135">Supplementary data</ce:section-title>
                  <ce:para id="p0225" view="all">Supplementary data to this article can be found online at <ce:inter-ref xlink:href="doi:10.1016/j.jcf.2016.02.013" id="ir0010" xlink:type="simple">http://dx.doi.org/10.1016/j.jcf.2016.02.013</ce:inter-ref>.</ce:para>
               </ce:section>
            </ce:appendices>
         </body>
         <tail view="all">
            <ce:bibliography id="bi0005" view="all">
               <ce:section-title id="st0140">References</ce:section-title>
               <ce:bibliography-sec id="bs0005" view="all">
                  <ce:bib-reference id="bb0005">
                     <ce:label>[1]</ce:label>
                     <sb:reference id="rf0005">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Welsh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.E.</ce:given-name>
                                 <ce:surname>Smith</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>73</sb:volume-nr>
                              </sb:series>
                              <sb:date>1993</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1251</sb:first-page>
                              <sb:last-page>1254</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0010">
                     <ce:label>[2]</ce:label>
                     <sb:reference id="rf0010">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Kerem</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Rommens</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Buchanan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Markiewicz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.K.</ce:given-name>
                                 <ce:surname>Cox</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Chakravarti</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of the cystic fibrosis gene: genetic analysis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>245</sb:volume-nr>
                              </sb:series>
                              <sb:date>1989</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1073</sb:first-page>
                              <sb:last-page>1080</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0015">
                     <ce:label>[3]</ce:label>
                     <sb:reference id="rf0015">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Riordan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Rommens</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Kerem</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Alon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Rozmahel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Grzelczak</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>245</sb:volume-nr>
                              </sb:series>
                              <sb:date>1989</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1066</sb:first-page>
                              <sb:last-page>1073</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0020">
                     <ce:label>[4]</ce:label>
                     <sb:reference id="rf0020">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Rommens</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.C.</ce:given-name>
                                 <ce:surname>Iannuzzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Kerem</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.L.</ce:given-name>
                                 <ce:surname>Drumm</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Melmer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Dean</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of the cystic fibrosis gene: chromosome walking and jumping</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>245</sb:volume-nr>
                              </sb:series>
                              <sb:date>1989</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1059</sb:first-page>
                              <sb:last-page>1065</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0025">
                     <ce:label>[5]</ce:label>
                     <sb:reference id="rf0025">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Marks</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Thorogood</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Neil</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.E.</ce:given-name>
                                 <ce:surname>Humphries</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.A.</ce:given-name>
                                 <ce:surname>Neil</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J Med Screen</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:date>2006</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>156</sb:first-page>
                              <sb:last-page>159</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0030">
                     <ce:label>[6]</ce:label>
                     <sb:reference id="rf0030">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Baig</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Din</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Hassan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Azhar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Baig</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Aslam</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Prevention of beta-thalassemia in a large Pakistani family through cascade testing</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Community Genet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>11</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>68</sb:first-page>
                              <sb:last-page>70</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0035">
                     <ce:label>[7]</ce:label>
                     <sb:reference id="rf0035">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Cody</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Green</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>McDevitt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.A.</ce:given-name>
                                 <ce:surname>Lynch</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cascade screening in BRCA1/2 mutation carriers</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Ir Med J</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>101</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>140</sb:first-page>
                              <sb:last-page>142</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0040">
                     <ce:label>[8]</ce:label>
                     <sb:reference id="rf0040">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.T.</ce:given-name>
                                 <ce:surname>Helderman-van den Enden</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>van den Bergen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.H.</ce:given-name>
                                 <ce:surname>Breuning</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Verschuuren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Tibben</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Bakker</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level?</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Clin Genet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>79</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>236</sb:first-page>
                              <sb:last-page>242</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0045">
                     <ce:label>[9]</ce:label>
                     <sb:reference id="rf0045">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Castellani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Picci</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Tridello</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Casati</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Tamanini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Bartoloni</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cystic fibrosis carrier screening effects on birth prevalence and newborn screening</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Genet Med</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>145</sb:first-page>
                              <sb:last-page>151</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0050">
                     <ce:label>[10]</ce:label>
                     <sb:reference id="rf0050">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Massie</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Carrier screening for cystic fibrosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Lancet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>374</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>978</sb:first-page>
                           </sb:pages>
                        </sb:host>
                        <sb:comment>[author reply]</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0055">
                     <ce:label>[11]</ce:label>
                     <sb:reference id="rf0055">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.V.</ce:given-name>
                                 <ce:surname>Zvereff</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Faruki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Edwards</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.J.</ce:given-name>
                                 <ce:surname>Friedman</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cystic fibrosis carrier screening in a North American population</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Genet Med</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>16</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>539</sb:first-page>
                              <sb:last-page>546</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0060">
                     <ce:label>[12]</ce:label>
                     <sb:reference id="rf0060">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Turner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Meagher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Willis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Colley</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cascade testing for carrier status in cystic fibrosis in a large family</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Med J Aust</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>159</sb:volume-nr>
                              </sb:series>
                              <sb:date>1993</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>163</sb:first-page>
                              <sb:last-page>165</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0065">
                     <ce:label>[13]</ce:label>
                     <sb:reference id="rf0065">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Super</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Schwarz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Malone</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Roberts</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Haworth</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Dermody</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Active cascade testing for carriers of cystic fibrosis gene</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>BMJ</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>308</sb:volume-nr>
                              </sb:series>
                              <sb:date>1994</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1462</sb:first-page>
                              <sb:last-page>1467</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0070">
                     <ce:label>[14]</ce:label>
                     <sb:reference id="rf0070">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.C.</ce:given-name>
                                 <ce:surname>Surh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Cappelli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.E.</ce:given-name>
                                 <ce:surname>MacDonald</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Mettler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.E.</ce:given-name>
                                 <ce:surname>Dales</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cystic fibrosis carrier screening in a high-risk population. participation based on a traditional recruitment process</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Arch Pediatr Adolesc Med</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>148</sb:volume-nr>
                              </sb:series>
                              <sb:date>1994</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>632</sb:first-page>
                              <sb:last-page>637</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0075">
                     <ce:label>[15]</ce:label>
                     <sb:reference id="rf0075">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Sorenson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Cheuvront</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>DeVellis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Callanan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Silverman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Koch</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am J Med Genet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>70</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>121</sb:first-page>
                              <sb:last-page>129</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0080">
                     <ce:label>[16]</ce:label>
                     <sb:reference id="rf0080">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Borgo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Castellani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Bonizzato</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Rolfini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Altieri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Zanolla</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Carrier testing program in a high-risk cystic fibrosis population from northeastern Italy. Active recruitment of relatives via probands' parents</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Community Genet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>2</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>82</sb:first-page>
                              <sb:last-page>90</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0085">
                     <ce:label>[17]</ce:label>
                     <sb:reference id="rf0085">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Lafayette</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Abuelo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Passero</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.</ce:given-name>
                                 <ce:surname>Tantravahi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Attitudes toward cystic fibrosis carrier and prenatal testing and utilization of carrier testing among relatives of individuals with cystic fibrosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J Genet Couns</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>8</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>17</sb:first-page>
                              <sb:last-page>36</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0090">
                     <ce:label>[18]</ce:label>
                     <sb:reference id="rf0090">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.J.</ce:given-name>
                                 <ce:surname>McClaren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.A.</ce:given-name>
                                 <ce:surname>Metcalfe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Aitken</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Massie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.C.</ce:given-name>
                                 <ce:surname>Ukoumunne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.J.</ce:given-name>
                                 <ce:surname>Amor</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur J Hum Genet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1084</sb:first-page>
                              <sb:last-page>1089</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0095">
                     <ce:label>[19]</ce:label>
                     <sb:reference id="rf0095">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Scotet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Gillet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Dugueperoux</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Audrezet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Bellis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Garnier</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Hum Genet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>111</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>247</sb:first-page>
                              <sb:last-page>254</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0100">
                     <ce:label>[20]</ce:label>
                     <sb:reference id="rf0100">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Audrezet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Munck</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Scotet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Claustres</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Roussey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Delmas</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Genet Med</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>17</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>108</sb:first-page>
                              <sb:last-page>116</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0105">
                     <ce:label>[21]</ce:label>
                     <sb:reference id="rf0105">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ferec</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Audrezet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Mercier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Guillermit</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Moullier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Quere</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Detection of over 98% cystic fibrosis mutations in a Celtic population</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat Genet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>1</sb:volume-nr>
                              </sb:series>
                              <sb:date>1992</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>188</sb:first-page>
                              <sb:last-page>191</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0110">
                     <ce:label>[22]</ce:label>
                     <sb:reference id="rf0110">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Scotet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>de Braekeleer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Roussey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Rault</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Parent</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Dagorne</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10<ce:hsp sp="0.25"/>years' experience and impact on prenatal diagnosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Lancet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>356</sb:volume-nr>
                              </sb:series>
                              <sb:date>2000</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>789</sb:first-page>
                              <sb:last-page>794</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0115">
                     <ce:label>[23]</ce:label>
                     <sb:reference id="rf0115">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Hanley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Negassa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.D.</ce:given-name>
                                 <ce:surname>Edwardes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Forrester</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Statistical analysis of correlated data using generalized estimating equations: an orientation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am J Epidemiol</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>157</sb:volume-nr>
                              </sb:series>
                              <sb:date>2003</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>364</sb:first-page>
                              <sb:last-page>375</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0120">
                     <ce:label>[24]</ce:label>
                     <sb:reference id="rf0120">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Scotet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Dugueperoux</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Audrezet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Blayau</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Boisseau</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Journel</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Prenatal diagnosis of cystic fibrosis: the 18-year experience of Brittany (western France)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Prenat Diagn</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>28</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>197</sb:first-page>
                              <sb:last-page>202</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0125">
                     <ce:label>[25]</ce:label>
                     <sb:reference id="rf0125">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Dugueperoux</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Audrezet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Parent</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Audebert-Bellanger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Roussey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ferec</ce:surname>
                              </sb:author>
                              <sb:et-al/>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cascade testing in families of carriers identified through newborn screening in Western Brittany (France)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J Cyst Fibros</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>12</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>338</sb:first-page>
                              <sb:last-page>344</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0130">
                     <ce:label>[26]</ce:label>
                     <sb:reference id="rf0130">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Forrest</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Delatycki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Curnow</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Gen Couns</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Skene</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Aitken</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>An audit of clinical service examining the uptake of genetic testing by at-risk family members</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Genet Med</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>14</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>122</sb:first-page>
                              <sb:last-page>128</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0135">
                     <ce:label>[27]</ce:label>
                     <sb:reference id="rf0135">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>d'Agincourt-Canning</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Baird</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Crit Rev Oncol Hematol</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>58</sb:volume-nr>
                              </sb:series>
                              <sb:date>2006</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>114</sb:first-page>
                              <sb:last-page>123</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0140">
                     <ce:label>[28]</ce:label>
                     <sb:reference id="rf0140">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Harel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Abuelo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Kazura</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Adolescents and genetic testing: what do they think about it?</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J Adolesc Health</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>33</sb:volume-nr>
                              </sb:series>
                              <sb:date>2003</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>489</sb:first-page>
                              <sb:last-page>494</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0145">
                     <ce:label>[29]</ce:label>
                     <sb:reference id="rf0145">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Sweeny</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Ghane</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Legg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.P.</ce:given-name>
                                 <ce:surname>Huynh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.E.</ce:given-name>
                                 <ce:surname>Andrews</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Predictors of genetic testing decisions: a systematic review and critique of the literature</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J Genet Couns</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>23</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>263</sb:first-page>
                              <sb:last-page>288</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0150">
                     <ce:label>[30]</ce:label>
                     <sb:reference id="rf0150">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.D.</ce:given-name>
                                 <ce:surname>Braekeleer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Bellis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Rault</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Allard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Milot</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Simard</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Disease knowledge in a high-risk population for cystic fibrosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Patient Educ Couns</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>43</sb:volume-nr>
                              </sb:series>
                              <sb:date>2001</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>263</sb:first-page>
                              <sb:last-page>268</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0155">
                     <ce:label>[31]</ce:label>
                     <sb:reference id="rf0155">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Denayer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Evers-Kiebooms</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>De Boeck</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Van den Berghe</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Reproductive decision making of aunts and uncles of a child with cystic fibrosis: genetic risk perception and attitudes toward carrier identification and prenatal diagnosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am J Med Genet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>44</sb:volume-nr>
                              </sb:series>
                              <sb:date>1992</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>104</sb:first-page>
                              <sb:last-page>111</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0160">
                     <ce:label>[32]</ce:label>
                     <sb:reference id="rf0160">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.R.</ce:given-name>
                                 <ce:surname>Miller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.H.</ce:given-name>
                                 <ce:surname>Schwartz</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Attitudes toward genetic testing of Amish, Mennonite, and Hutterite families with cystic fibrosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am J Public Health</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>82</sb:volume-nr>
                              </sb:series>
                              <sb:date>1992</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>236</sb:first-page>
                              <sb:last-page>242</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0165">
                     <ce:label>[33]</ce:label>
                     <sb:reference id="rf0165">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.J.</ce:given-name>
                                 <ce:surname>McClaren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Aitken</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Massie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Amor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.C.</ce:given-name>
                                 <ce:surname>Ukoumunne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.A.</ce:given-name>
                                 <ce:surname>Metcalfe</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Genet Med</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>15</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>533</sb:first-page>
                              <sb:last-page>540</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bb0170">
                     <ce:label>[34]</ce:label>
                     <sb:reference id="rf0170">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Henneman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Kooij</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Bouman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.P.</ce:given-name>
                                 <ce:surname>ten Kate</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Am J Med Genet</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>110</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>324</sb:first-page>
                              <sb:last-page>331</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item>
</xocs:doc></originalText></full-text-retrieval-response>